Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Trial of Prasugrel Plus Bivalirudin vs. Clopidogrel Plus Heparin in Patients With Acute STEMI.

Next Previous
Trial Profile

Randomized Trial of Prasugrel Plus Bivalirudin vs. Clopidogrel Plus Heparin in Patients With Acute STEMI.

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Nov 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bivalirudin (Primary) ; Prasugrel (Primary) ; Clopidogrel; Heparin
  • Indications Myocardial infarction
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BRAVE-4

Most Recent Events

  • 21 Jan 2014 Planned End Date changed from 1 Jul 2013 to 1 Feb 2015 according to ClinicalTrials.gov record.
  • 21 Jan 2014 Status changed from recruiting to active, no longer recruiting; according to ClinicalTrials.gov record.
  • 18 Sep 2009 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top